Connection

Co-Authors

This is a "connection" page, showing publications co-authored by DARREN WOODSIDE and PETER VANDERSLICE.
Connection Strength

1.583
  1. Cell adhesion antagonists: therapeutic potential in asthma and chronic obstructive pulmonary disease. BioDrugs. 2008; 22(2):85-100.
    View in: PubMed
    Score: 0.293
  2. Integrin antagonists as therapeutics for inflammatory diseases. Expert Opin Investig Drugs. 2006 Oct; 15(10):1235-55.
    View in: PubMed
    Score: 0.268
  3. Contrasting roles for domain 4 of VCAM-1 in the regulation of cell adhesion and soluble VCAM-1 binding to integrin alpha4beta1. J Immunol. 2006 Apr 15; 176(8):5041-9.
    View in: PubMed
    Score: 0.260
  4. Identification of Inhibitors of Integrin Cytoplasmic Domain Interactions With Syk. Front Immunol. 2020; 11:575085.
    View in: PubMed
    Score: 0.180
  5. Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin a4?1. Sci Rep. 2018 02 27; 8(1):3733.
    View in: PubMed
    Score: 0.148
  6. Small molecule agonist of very late antigen-4 (VLA-4) integrin induces progenitor cell adhesion. J Biol Chem. 2013 Jul 05; 288(27):19414-28.
    View in: PubMed
    Score: 0.106
  7. Potent in vivo suppression of inflammation by selectively targeting the high affinity conformation of integrin a4?1. Biochem Biophys Res Commun. 2010 Oct 01; 400(4):619-24.
    View in: PubMed
    Score: 0.088
  8. Development of cell adhesion molecule antagonists as therapeutics for asthma and COPD. Pulm Pharmacol Ther. 2004; 17(1):1-10.
    View in: PubMed
    Score: 0.055
  9. LFA-1 activation enriches tumor-specific T cells in a cold tumor model and synergizes with CTLA-4 blockade. J Clin Invest. 2022 07 01; 132(13).
    View in: PubMed
    Score: 0.050
  10. Use of a small molecule integrin activator as a systemically administered vaccine adjuvant in controlling Chagas disease. NPJ Vaccines. 2021 Sep 08; 6(1):114.
    View in: PubMed
    Score: 0.047
  11. Regulation of human T lymphocyte coactivation with an alpha4 integrin antagonist peptide. J Immunol. 1997 May 01; 158(9):4180-6.
    View in: PubMed
    Score: 0.035
  12. Treatment of hind limb ischemia using angiogenic peptide nanofibers. Biomaterials. 2016 08; 98:113-9.
    View in: PubMed
    Score: 0.033
  13. Clustering T-cell GM1 lipid rafts increases cellular resistance to shear on fibronectin through changes in integrin affinity and cytoskeletal dynamics. Immunol Cell Biol. 2009 May-Jun; 87(4):324-36.
    View in: PubMed
    Score: 0.020
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.